Further, EGF-mediated activation of EGFR/erbB2/AKT signaling in the hearts via modulation of FOXO3a activity appears to be a critical survival pathway in preventing diabetes-mediated cardiac dysfunction. Here, FOXO3 is linked to diabetes mellitus.